Skip to main content
DOMHNasdaq

Dominari Holdings Inc.

·New York, NY, United States·CEO: Mr. Anthony C. Hayes Esq.

DOMH evidence brief

What we can confirm

No verified snapshot fields are available yet.

What it means

The company data is ready for cross-source review; unsupported conclusions remain unknown.

What to watch

Watch the next source-backed data update.
BioSniper AIPage evidence connected

Prepared research question

What matters most for DOMH—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

BioSniper AI · DOMH

Dominari Holdings Inc. (DOMH) is a financial services company that holds cash, marketable securities, and securities owned, and relies on its capital base and potential future financing to fund operations and execute its business strategy.

Key risk: Capital raising difficulty

3.6/10

BioSniper Score

Based on 2 of 6 signals

Limited data coverage

Market Cap

$57.9M

Cash Runway

7.6 mo

Lead Asset

Next Catalyst

Financial data as of Jun 30, 2026.

AI OverviewAI overview is shown in English only.

Dominari Holdings Inc. (DOMH) is a financial services company that holds cash, marketable securities, and securities owned, and relies on its capital base and potential future financing to fund operations and execute its business strategy.

  • Cash and cash equivalents of $25.0M as of 2026-06-30 [sec].
  • Total revenue of $16.6M for the period ended 2026-06-30 [sec].
  • Net loss of $5.0M for the period ended 2026-06-30 [sec].
  • Shareholders' equity of $69.4M as of 2026-06-30 [sec].
  • Working capital of approximately $15.8M as of June 30, 2026 [sec_mda · as of 2026-08-11].

What works

  • As of June 30, 2026, the company had $25.0M in cash and cash equivalents, $2.4M in marketable securities, and $4.5M in securities owned, providing a liquidity buffer [sec_mda · as of 2026-08-11].
  • Management believes existing cash, marketable securities, and anticipated cash flow from operations will be sufficient to meet working capital and capital expenditure requirements for at least the next 12 months [sec_mda · as of 2026-08-11].
  • The company has a receivable from clearing brokers of approximately $6.0M as of June 30, 2026, adding to available funds [sec_mda · as of 2026-08-11].

What to weigh

  • The company has a history of net losses, reporting a net loss of $5.0M for the period ended 2026-06-30 [sec].
  • Raising additional capital may be challenging due to volatility and weakness in public markets, which could affect the company's ability to fund operations if needed [sec_mda · as of 2026-08-11].
  • Any future debt financing could impose higher interest rates and shorter maturities, and equity financing could result in significant dilution to stockholders [sec_mda · as of 2026-08-11].
  • The company's ultimate success depends on generating sufficient cash flow to meet obligations on a timely basis, which is uncertain [sec_mda · as of 2026-05-13].

From the filings

Quoted directly from source documents.

  • Cash and cash equivalents as of June 30, 2026

    As of June 30, 2026, we had approximately $25.0 million of cash and cash equivalents

    SEC MD&A · August 11, 2026

  • Working capital as of June 30, 2026

    Our working capital amounted to approximately $15.8 million as of June 30, 2026.

    SEC MD&A · August 11, 2026

  • Risk of raising additional capital due to market conditions

    as a result of recent volatility and weakness in the public markets, due to, among other factors, uncertainty in the global economy and financial markets, it may be much more difficult to raise additional capital, if and when it is needed

    SEC MD&A · August 11, 2026

Risks & what to watch (4)

Key risks

  • Capital raising difficultyVolatile public markets may hinder raising additional capital when needed [sec_mda · as of 2026-08-11].
  • History of net lossesThe company reported a net loss of $5.0M for the period ended 2026-06-30 [sec].
  • Dependence on cash flowUltimate success depends on generating sufficient cash flow to meet obligations [sec_mda · as of 2026-05-13].
  • Dilution from equity financingIssuance of additional equity securities could result in significant dilution to stockholders [sec_mda · as of 2026-08-11].

What to watch

  • Ability to generate positive cash flow from operations to sustain the business [sec_mda · as of 2026-08-11].
  • Changes in cash and cash equivalents, marketable securities, and working capital in future filings [sec_mda · as of 2026-08-11].
  • Any announcements regarding debt or equity financing to support growth strategy [sec_mda · as of 2026-05-13].
  • Market conditions affecting the company's ability to raise capital [sec_mda · as of 2026-08-11].

Sources: SEC MD&A · Generated August 19, 2026 · How we verify sources →

Run Dominari Holdings Inc. through your own thesis

Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.

Your protocol can:

  • Turn available Dominari Holdings Inc. facts into screen rules or deeper checks
  • Show cited findings, blockers, and unresolved evidence together
  • Save the logic and rerun it as the company evidence changes
Run a thesis on this company — freeRun a thesis on this company

Evidence & data

Score breakdownBased on 2 of 6 signals · derived from public data

No clinical pipeline tracked — this score reflects financial & catalyst signals only.

Cash Runway2.1

7.6 months

Financial Health5.1

D/E 1.63

Pipeline MaturityN/A

No tracked pipeline phase

Pipeline BreadthN/A

No tracked pipeline candidates

Catalyst MomentumN/A

No upcoming catalysts tracked

Insider SignalN/A

No insider transactions in the last 180 days

Runway

Financials

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

29

Total value held

$4.4M

Showing top 10 of 29 institutional holders of Dominari Holdings Inc.. Open the full 13F history after sign-in.

Short Interest

as of May 20, 2026
% of float
4.1%
Days to cover
4.4
Shares short
480,910
Daily short volume
-

Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →

DOMH short interest

Governance

Frequently asked questions

What is the AI investment thesis for Dominari Holdings Inc.?

Dominari Holdings Inc. (DOMH) is a financial services company that holds cash, marketable securities, and securities owned, and relies on its capital base and potential future financing to fund operations and execute its business strategy.

Who is the CEO of Dominari Holdings Inc.?

Mr. Anthony C. Hayes Esq. is the chief executive officer of Dominari Holdings Inc. (DOMH).

Where is Dominari Holdings Inc. headquartered?

Dominari Holdings Inc. (DOMH) is headquartered in New York, NY, United States.

925 companies232,681 SEC filings21,419 clinical trials100% citation-verification pass rate (7d)How we verify →

The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.